Sentence examples for more advanced baseline from inspiring English sources

Overall, most incremental benefits of treatment with donepezil 23 mg/day over 10 mg/day were seen in patients with more advanced baseline disease (MMSE 0 to 15).

Early worsening occurred most frequently in subjects with more advanced baseline DR, and was predominantly driven by the development of cotton wool spots and intraretinal microvascular abnormalities.

In general the pattern was consistent with the trend observed in the total cohort standardised incidence ratios increased with more advanced baseline mucosal lesions.

31 Moreover, the significant language benefits of donepezil 23 mg/day over 10 mg/day were not only evident in the overall study population, but also more prominent in patient subgroups based on more advanced baseline AD (MMSE scores 0 16) and on concomitant use of memantine.

Patients who died had lower median CD4 counts and more advanced disease at baseline, compared to the other two groups, in each of the treatment programmes.

Since there were no significant differences between patients' demographic, clinical status and socioeconomic status, there was no evidence to suggest that deprived patients had more advanced disease at baseline.

Finally, this was a hospital based study and probably there was a selection bias towards more advanced immunodeficiency at baseline, which has previously been shown to increase the risk of drug resistance [ 35].

This can not readily be explained by more advanced disease at baseline, higher HIV-1 plasma viral loads, or different HSV-2 seroprevalence - an infection known to potentially enhance HIV-1 replication and disease progression [ 37].

Mortality rates were higher in participants with more advanced CKD at baseline: In those initially at CKD stages 3, 4, and 5, annual mortality rates were 3.9%, 6.3%, and 9.2%, respectively (between-group comparison, P = 0.001; Fig 1).

Presence of diseases such as oral thrush [ 12, 32] also indicates immunocompromise in the patient and suggests that these patients had more advanced disease at baseline, leading to greater mortality.

Moreover, the rise in adjusted risk from 1.5 in people with mild nonproliferative retinopathy (vs. no retinopathy) to 2.4 in people with severe retinopathy demonstrates that more advanced retinopathy at baseline predicts a higher risk of serious outcomes.